Emcure Pharmaceuticals Ltd

Pharmaceuticals

Offer Period :

3rd to 7th Jul 2024

Emcure Pharmaceuticals is a top Indian company developing, manufacturing, and marketing pharmaceuticals globally. Ranking 13th in domestic sales, Read more... it operates in 70+ countries with strong R&D, 350+ brands, 5 R&D centers, and 13 manufacturing facilities, delivering quality healthcare solutions.Read less

Emcure Pharmaceuticals Ltd IPO Details

IPO Date 3rd to 7th Jul 2024 Minimum Investment ₹14112 / 1 Lots
Listing Date 2024-07-10 Maximum Investment ₹197568 / 14 Lots
Face Value ₹10 per share Total Issue Size ₹1952.03 Crores
Price ₹1008 to ₹1008 per share Fresh Issue ₹800 Crores
Lot Size 1 Lots (14 Shares) Offer For Sale ₹ 1152.03
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹ 0.98    
IPO Date 3rd to 7th Jul 2024
Listing Date 2024-07-10
Face Value ₹10 per share
Price ₹1008 to ₹1008 per share
Lot Size 1 Lots (14 Shares)
Listing At BSE, NSE
Employee Discount ₹0.98 Crores
Minimum Investment ₹14112 / 1 Lots
Maximum Investment ₹197568 / 14 Lots
Total Issue Size ₹1952.03 Crores
Fresh Issue ₹800 Crores
Offer For Sale
Retail Discount ₹ 0

Tentative Timeline

Important dates for allocation and IPO listing.

3rd Jul

IPO Starts

5th Jul

IPO Ends

8th Jul

Allotment Date

9th Jul

Initiation of Refund

9th Jul

Credit of Shares to Demat Account

10th Jul

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 54.42 0
Public Group 45.58 100

Emcure Pharmaceuticals Ltd IPO Reservation

QIB Shares Offered 3851290(19.89%)
NII (HNI) Shares Offered 2888467(14.92%)
Retail Shares Offered 6739756(34.8%)
Anchor Investor Shares Offered 5776934(29.83%)
Total Shares Offered 19365348
Total Shares With Anchor Investor 19365348

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Emcure Pharmaceuticals Ltd IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id emcure.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Emcure Pharmaceuticals Ltd IPO Lead Manager

1. Axis Capital Ltd

2. Kotak Mahindra Capital Company Ltd

3. Jefferies India Pvt Ltd

4. J.P. Morgan India Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Emcure Pharmaceuticals Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 38,53,234 0 77,734.0
Non Institutional Investors (NIIs) 28,89,926 7,60,004 77,734.0
Non Institutional Investors (Bid amount of more than Ten Lakh Rupees) 19,26,618 4,72,486 77,734.0
Non Institutional Investors (Bid amount of more than Two Lakh and upto Ten Lakh Rupees) 9,63,309 2,87,518 77,734.0
Retail Individual Investors (RIIs) 67,43,160 16,90,038 77,734.0
Total 1,34,86,320 24,95,990 77,734.0

Strength of Emcure Pharmaceuticals Ltd

1. Well-placed to leverage leading position in the domestic market.

2. Demonstrated capabilities of building brands.

3. Large, diversified and fast-growing product portfolio in international markets.

4. Strong R&D capabilities driving differentiated portfolio of products.

5. Extensive and diversified manufacturing capacity.

6. Highly qualified, experienced and entrepreneurial management team and its Board.

Risks Involved

1. Any manufacturing or quality control problems may damage its reputation, subject it to regulatory action, and expose it to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.

2. Its failures to comply with applicable quality standards may result in product liability claims, which could adversely affect its business, financial condition, cash flows and results of operations.

3. Its manufacturing and research and development operations are subject to operational risks. Any slowdown or shutdown in its manufacturing or research and development operations could adversely affect its business, financial condition and results of operations.

4. The company is subject to extensive government regulations and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required to operate its business, the company's business, financial condition, results of operations and cash flows may be adversely affected.

5. Any disruptions to the supply, or increases in the pricing, of the raw materials and finished products that its outsource, may adversely affect the supply and pricing of its products and, in turn, adversely affect the company's business, cash flows, financial condition and results of operations.

6. The company has significant working capital requirements. If its experience insufficient cash flows to fund the company working capital requirements or if the company is not able to provide collateral to obtain letters of credit and bank guarantees in sufficient quantities, there may be an adverse effect on its business, financial condition, results of operations and cash flows.

7. Its inability to meet the company obligations, including financial and other covenants under its debt financing arrangements could adversely affect its business, financial condition, results of operations and cash flows.

8. Its inability to accurately forecast demand for the company products and manage our inventory may have an adverse effect on its business, financial condition, results of operations and cash flows.

9. The company is dependent on third parties for the distribution and marketing of its products. If the company does not maintain and increase the number of its arrangements for the marketing and distribution of its products, the company business, financial condition and results of operations could be adversely affected.

10. The determination of the Price Band is based on various factors and assumptions and the Offer Price of the Equity Shares, market capitalization and price to earnings ratio based on the Offer Price of the Equity Shares, may not be indicative of the market price of the Company on listing or thereafter.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 7806.16 6672.53 6063.47
Total Liabilities 7806.16 6672.53 6063.47
Total Expenses 5978.08 5278.35 4946.31
Total Revenue 
6715.24 6031.72 5918.86
Profit After Tax 498.18 532.02 662.2
EBITDA 1276.78 1220.94 1393.38
Adjusted EBITDA 0 0 0

Emcure Pharmaceuticals Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-07-10 544210 EMCURE
INE168P01015
₹1008 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹1008 ₹1008
Open ₹1325.05 ₹1325.05
Low ₹1325.05 ₹1325.05
High ₹1384 ₹1385
Low ₹1325.05 ₹1325.05

Frequently Asked Questions

What is Emcure Pharmaceuticals Ltd IPO?

Answer Field

Emcure Pharmaceuticals Ltd IPO is a Mainboard IPO of 1,93,65,348 equity shares of a face value of ₹10 aggregating up to ₹1952.03 Crores. The issue is priced at ₹1008 to ₹1008 per share. The minimum order quantity is 14 Shares. The IPO opens on July 03, 2024, and closes on July 05, 2024. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Emcure Pharmaceuticals Ltd IPO will open?

Answer Field

The Emcure Pharmaceuticals Ltd IPO opens on July 03, 2024 and closes on July 05, 2024.

What is the lot size of Emcure Pharmaceuticals Ltd?

Answer Field

Emcure Pharmaceuticals Ltd lot size is 14 shares, and the minimum amount required is ₹14,112.

How to apply for Emcure Pharmaceuticals Ltd IPO?

Answer Field

You can apply in Emcure Pharmaceuticals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Emcure Pharmaceuticals Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Emcure Pharmaceuticals Ltd IPO will be done on July 08, 2024, and the allotted shares will be credited to your demat account by July 09, 2024.

When is Emcure Pharmaceuticals Ltd IPO listing date?

Answer Field

The Emcure Pharmaceuticals Ltd listing date is July 10, 2024.

Who is the registrar of Emcure Pharmaceuticals Ltd IPO?

Answer Field

The registrar of Emcure Pharmaceuticals Ltd IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Axis Capital Ltd,Kotak Mahindra Capital Company Ltd,Jefferies India Pvt Ltd,J.P. Morgan India Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Emcure Pharmaceuticals Ltd IPO?

Answer Field

The fresh issue size is ₹800 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Emcure Pharmaceuticals Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 14 shares and ₹14,112 amount.

How can I approve the UPI mandate request for Emcure Pharmaceuticals Ltd IPO?

Answer Field

To apply for Emcure Pharmaceuticals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Emcure Pharmaceuticals Ltd?

Answer Field

The price of each Emcure Pharmaceuticals Ltd share will be ranging in between ₹1008 to ₹1008 per share.

What is the cut-off time for the UPI mandate for Emcure Pharmaceuticals Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, July 05, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SANSTAR LIMITEDMainboard IPO

  • Bidding Dates

    19th Jul 2024 - 7th Jul 2024

  • Price Range

    ₹90 - 95

  • IPO Size

    ₹5,10,15,00,000

  • Apply Now
  • RNFI SERVICES LIMITEDSME IPO

  • Bidding Dates

    22nd Jul 2024 - 7th Jul 2024

  • Price Range

    ₹98 - 105

  • IPO Size

    ₹70,81,00,000

  • Apply Now
  • SAR TELEVENTURE LIMITEDSME IPO

  • Bidding Dates

    22nd Jul 2024 - 7th Jul 2024

  • Price Range

    ₹200 - 210

  • IPO Size

    ₹1,50,00,00,000

  • Apply Now
  • VLINFRAPROJECTS LIMITEDSME IPO Early Access

  • Bidding Dates

    23rd Jul 2024 - 7th Jul 2024

  • Price Range

    ₹39 - 42

  • IPO Size

    ₹18,52,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • SAHAJ SOLAR LIMITEDSME IPO

  • Issue Price

    180.00

  • Listing Day Close

    359.10

  • Listing Day (Gain/Loss)

    99.44

  • EFFWA INFRA AND RESEARCH LIMITEDSME IPO

  • Issue Price

    82.00

  • Listing Day Close

    163.55

  • Listing Day (Gain/Loss)

    100.00

  • GANESH GREEN BHARAT LIMITEDSME IPO

  • Issue Price

    190.00

  • Listing Day Close

    379.05

  • Listing Day (Gain/Loss)

    99.47

  • AMBEY LABORATORIES LIMITEDSME IPO

  • Issue Price

    68.00

  • Listing Day Close

    89.25

  • Listing Day (Gain/Loss)

    30.88

  • BANSAL WIRE INDUSTRIES LIMITEDMainboard IPO

  • Issue Price

    256.00

  • Listing Day Close

    350.30

  • Listing Day (Gain/Loss)

    36.72

  • EMCURE PHARMACEUTICALS LIMITEDMainboard IPO

  • Issue Price

    1008.00

  • Listing Day Close

    1358.85

  • Listing Day (Gain/Loss)

    34.82

  • NEPHRO CARE INDIA LIMITEDSME IPO

  • Issue Price

    90.00

  • Listing Day Close

    179.55

  • Listing Day (Gain/Loss)

    100.00

  • DIENSTEN TECH LIMITEDSME IPO

  • Issue Price

    100.00

  • Listing Day Close

    252.00

  • Listing Day (Gain/Loss)

    152.00

  • VRAJ IRON AND STEEL LIMITEDMainboard IPO

  • Issue Price

    207.00

  • Listing Day Close

    251.95

  • Listing Day (Gain/Loss)

    21.74

  • AKIKO GLOBAL SERVICES LIMITEDSME IPO

  • Issue Price

    77.00

  • Listing Day Close

    93.35

  • Listing Day (Gain/Loss)

    20.78

  • PETRO CARBON AND CHEMICALS LIMITEDSME IPO

  • Issue Price

    171.00

  • Listing Day Close

    315.00

  • Listing Day (Gain/Loss)

    84.21

  • DIVINE POWER ENERGY LIMITEDSME IPO

  • Issue Price

    40.00

  • Listing Day Close

    152.30

  • Listing Day (Gain/Loss)

    280.00

  • VISAMAN GLOBAL SALES LIMITEDSME IPO

  • Issue Price

    43.00

  • Listing Day Close

    47.35

  • Listing Day (Gain/Loss)

    9.30

  • SHIVALIC POWER CONTROL LIMITEDSME IPO

  • Issue Price

    100.00

  • Listing Day Close

    326.55

  • Listing Day (Gain/Loss)

    227.00

  • MASON INFRATECH LIMITEDSME IPO

  • Issue Price

    64.00

  • Listing Day Close

    92.40

  • Listing Day (Gain/Loss)

    43.75

  • SYLVAN PLYBOARD INDIA LIMITEDSME IPO

  • Issue Price

    55.00

  • Listing Day Close

    69.30

  • Listing Day (Gain/Loss)

    25.45

  • MEDICAMEN ORGANICS LIMITEDSME IPO

  • Issue Price

    34.00

  • Listing Day Close

    144.70

  • Listing Day (Gain/Loss)

    326.47

  • STANLEY LIFESTYLES LIMITEDMainboard IPO

  • Issue Price

    369.00

  • Listing Day Close

    474.00

  • Listing Day (Gain/Loss)

    28.46

  • WINNY IMMIGRATION AND EDUCATION SERVICES LIMITEDSME IPO

  • Issue Price

    140.00

  • Listing Day Close

    252.00

  • Listing Day (Gain/Loss)

    80.00

  • AKME FINTRADE INDIA LIMITEDMainboard IPO

  • Issue Price

    120.00

  • Listing Day Close

    131.95

  • Listing Day (Gain/Loss)

    10.00

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text